Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$3.23 - $5.87 $74,464 - $135,326
-23,054 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.46 - $3.37 $33,658 - $77,691
23,054 New
23,054 $103,000
Q3 2018

Nov 14, 2018

SELL
$2.67 - $4.23 $90,398 - $143,215
-33,857 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.2 - $4.74 $108,342 - $160,482
33,857 New
33,857 $128,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $78.9M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.